Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Mass drug administration approved and candidate anthelmintics beginning on larval stage 1 Caenorhabditis elegans are generally potent, suggesting a novel, pre-infective control for helminths

  • Sam A. Attalla,
  • Kathryn J. Isaac,
  • Morgan Pfeffer,
  • Justin R. Hockaday,
  • Raegan Weatherly,
  • Malia B. Asselin,
  • Allison K. Lewis,
  • Viveke Rai,
  • William A. Huff Jr,
  • Mason H. Long,
  • Tashna Placide,
  • Kala R. Pearce,
  • Leopold N. Nkengbeza,
  • Anna K. Thurman,
  • Audrey L. Cox,
  • Giselle Domingo Diaz,
  • Jasmine Carter,
  • Nathan Stein,
  • Sam Fischer,
  •  [ ... ],
  • Brian L. Ellis
  • [ view all ]
  • [ view less ]

S2 Table was uploaded incorrectly. Please see the correct S2 Table here.

Supporting information

S2 Table. P-values for Two-Way ANOVA with Dunnett’s multiple comparisons tests for each drug tested (utilizing 3 − 0 and 2 − 0 motility data and 1 − 0 mortality data).

P-values for the Two-Way ANOVA analyses and each factor’s percent of total variation are reported here. P-values for Dunnett’s multiple comparisons tests are also presented, comparing the experimental versus control for each day and drug. ns = not significant, while the asterisks denote the significance level (from * to ****). N/A = Not Applicable, utilized if the concentration was not tested for the given drug.

https://doi.org/10.1371/journal.pone.0355879.s001

(PDF)

Reference

  1. 1. Attalla SA, Isaac KJ, Pfeffer M, Hockaday JR, Weatherly R, Asselin MB, et al. Mass drug administration approved and candidate anthelmintics beginning on larval stage 1 Caenorhabditis elegans are generally potent, suggesting a novel, pre-infective control for helminths. PLoS One. 2026;21(4):e0346795. pmid:41996472

Citation: Attalla SA, Isaac KJ, Pfeffer M, Hockaday JR, Weatherly R, Asselin MB, et al. (2026) Correction: Mass drug administration approved and candidate anthelmintics beginning on larval stage 1 Caenorhabditis elegans are generally potent, suggesting a novel, pre-infective control for helminths. PLoS One 21(8): e0355879. https://doi.org/10.1371/journal.pone.0355879

Published: August 11, 2026

Copyright: © 2026 Attalla et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.